Common misconceptions

Common mistake
Wrong: Diarrhea in ZES is caused by the tumor mass obstructing the bowel.
Right: Diarrhea in ZES results from massive acid hypersecretion inactivating pancreatic lipase and damaging intestinal mucosa, causing secretory and malabsorptive diarrhea.
The diarrhea in ZES has nothing to do with tumor bulk or obstruction — most gastrinomas are small. Instead, the massive volume of acid secreted into the duodenum overwhelms the gut's buffering capacity. This acidic environment inactivates pancreatic lipase (causing fat malabsorption) and directly damages the intestinal mucosa, producing a combination of secretory and malabsorptive diarrhea. Think of it as the downstream consequences of acid, not the tumor itself.
Common mistake
Wrong: Secretin administration suppresses gastrin levels in ZES, as it does in normal physiology.
Right: In ZES, secretin paradoxically stimulates gastrin release from the gastrinoma, causing a rise in serum gastrin ≥200 pg/mL — the basis of the secretin stimulation test.
In normal physiology, secretin inhibits gastrin release — it's a feedback brake. But gastrinoma cells don't respond to normal regulatory signals. When you give secretin to a ZES patient, the tumor paradoxically releases a surge of gastrin, causing serum gastrin to rise by ≥200 pg/mL above baseline. This paradoxical rise is the diagnostic basis of the secretin stimulation test. If you're expecting suppression, you'll misread the test entirely — remember: paradoxical rise = gastrinoma.
Common mistake
Wrong: ZES associated with MEN1 is caused by a single large gastrinoma that is easily resectable.
Right: ZES in MEN1 is typically caused by multiple small gastrinomas, often in the duodenum, and surgical cure is rarely achieved; parathyroid disease should be corrected first.
When ZES occurs sporadically, there's often a single resectable tumor, and surgery can be curative. But in MEN1, the gastrinomas are typically multiple and small, frequently scattered in the duodenal submucosa, making complete surgical resection nearly impossible. Cure rates with surgery in MEN1-ZES are very low. Additionally, because hyperparathyroidism (elevated calcium) directly stimulates gastrin secretion and worsens acid output, the parathyroid disease must be corrected first before any gastrinoma management.
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. Recognize the clinical red flags that distinguish ZES from routine peptic ulcer disease — including ulcers in atypical locations like the distal duodenum or jejunum, ulcer disease refractory to standard therapy, secretory diarrhea, and markedly elevated fasting serum gastrin levels.
  2. Know the diagnostic workup for ZES: when to suspect it, what a fasting serum gastrin level means, why acid output measurement matters, and how the secretin stimulation test is used to confirm the diagnosis (including what a positive result looks like).
  3. Understand the association between ZES and MEN1 — what other tumors to look for, why MEN1-associated gastrinomas are surgically challenging, and why hypercalcemia from hyperparathyroidism should be corrected before addressing the gastrinoma.

Can you avoid these mistakes?

A 42-year-old man has recurrent ulcers in the distal duodenum despite maximal PPI therapy, along with a 15 lb weight loss and chronic watery diarrhea. Fasting serum gastrin comes back at 850 pg/mL. What is the most likely diagnosis, and what test would you order next to confirm it?
A patient with ZES is given an IV secretin injection as part of their diagnostic workup. Their serum gastrin level rises by 350 pg/mL. Your colleague says this means the test is negative because secretin should increase gastrin. Who is right, and why?
A patient is diagnosed with ZES and found to have MEN1. Imaging shows multiple small gastrinomas in the duodenal wall. Labs show hypercalcemia. In what order should these problems be addressed, and why?
Explain mechanistically why a patient with ZES develops fat malabsorption and diarrhea, even though the tumor is not obstructing the bowel or pancreatic duct.

Related topics

See how your Anki deck covers this topic.

Upload your deck for a free audit →